• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病(COPD)患者使用沙丁胺醇后的吸气量及肺过度充气减少情况

Inspiratory capacity and decrease in lung hyperinflation with albuterol in COPD.

作者信息

Duranti Roberto, Filippelli Mario, Bianchi Roberto, Romagnoli Isabella, Pellegrino Riccardo, Brusasco Vito, Scano Giorgio

机构信息

Dipartimento di Medicina Interna, Università di Firenze, Viale G.B. Morgagni 85, 50134 Florence, Italy.

出版信息

Chest. 2002 Dec;122(6):2009-14. doi: 10.1378/chest.122.6.2009.

DOI:10.1378/chest.122.6.2009
PMID:12475840
Abstract

STUDY OBJECTIVES

Inspiratory capacity (IC) has been proposed as a simple method to assess acute changes in functional residual capacity (FRC) with bronchodilation, assuming that total lung capacity (TLC) is unchanged. This assumption is based on studies using body plethysmography, which may not accurately measure TLC in severely obstructed subjects. The aim of this study is to validate the use of IC measured by optoelectronic plethysmography (OEP) [ICOEP], a noninvasive technique capable of computing changes in absolute lung volumes with great accuracy. MEWTHODS AND MEASUREMENTS: We studied 13 subjects with COPD in clinically stable condition at baseline and after 200 microg of inhaled albuterol. Changes in lung volumes were obtained from changes in chest wall volume (Vcw) measured by OEP and were compared with those measured by standard techniques.

RESULTS

Albuterol treatment caused a small but significant increase in FEV(1) and FVC, a significant decrease of Vcw at FRC (VcwFRC), but no changes of Vcw at TLC (VcwTLC) and breathing pattern variables. The reduction of VcwFRC was not correlated with either spirometric or breathing-pattern variables. IC measured with a pneumotachograph was highly correlated with and not significantly different from ICOEP (p < 0.001).

CONCLUSIONS

A single dose of inhaled albuterol does not significantly modify VcwTLC in subjects with COPD, thus validating the use of IC to measure changes of FRC in the assessment of reversibility of airway obstruction.

摘要

研究目的

吸气容量(IC)已被提议作为一种简单方法,用于评估支气管扩张时功能残气量(FRC)的急性变化,前提是总肺容量(TLC)不变。这一假设基于使用体容积描记法的研究,但在严重阻塞性受试者中,该方法可能无法准确测量TLC。本研究的目的是验证通过光电容积描记法(OEP)[ICOEP]测量的IC的用途,这是一种能够高精度计算绝对肺容积变化的非侵入性技术。

方法与测量

我们研究了13例临床稳定的慢性阻塞性肺疾病(COPD)患者,在基线时以及吸入200微克沙丁胺醇后进行观察。肺容积变化通过OEP测量的胸壁容积(Vcw)变化获得,并与通过标准技术测量的结果进行比较。

结果

沙丁胺醇治疗导致第一秒用力呼气容积(FEV₁)和用力肺活量(FVC)有小幅但显著的增加,功能残气量时的胸壁容积(VcwFRC)显著降低,但总肺容量时的胸壁容积(VcwTLC)和呼吸模式变量无变化。VcwFRC的降低与肺量计测量值或呼吸模式变量均无相关性。用呼吸流速仪测量的IC与ICOEP高度相关且无显著差异(p < 0.001)。

结论

单剂量吸入沙丁胺醇不会显著改变COPD患者的VcwTLC,从而验证了在评估气道阻塞可逆性时使用IC来测量FRC变化的有效性。

相似文献

1
Inspiratory capacity and decrease in lung hyperinflation with albuterol in COPD.慢性阻塞性肺疾病(COPD)患者使用沙丁胺醇后的吸气量及肺过度充气减少情况
Chest. 2002 Dec;122(6):2009-14. doi: 10.1378/chest.122.6.2009.
2
Tiotropium and simplified detection of dynamic hyperinflation.噻托溴铵与动态肺过度充气的简易检测
Chest. 2007 Mar;131(3):690-695. doi: 10.1378/chest.06-1662.
3
Effect of salbutamol on lung function and chest wall volumes at rest and during exercise in COPD.沙丁胺醇对慢性阻塞性肺疾病(COPD)患者静息及运动时肺功能和胸壁容积的影响。
Thorax. 2005 Nov;60(11):916-24. doi: 10.1136/thx.2004.037937. Epub 2005 Jun 30.
4
Lung hyperinflation and flow limitation in chronic airway obstruction.慢性气道阻塞中的肺过度充气和气流受限。
Eur Respir J. 1997 Mar;10(3):543-9.
5
Lung hyperinflation and its reversibility in patients with airway obstruction of varying severity.不同严重程度气道阻塞患者的肺过度充气及其可逆性。
COPD. 2010 Dec;7(6):428-37. doi: 10.3109/15412555.2010.528087.
6
Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease.吸入性支气管扩张剂可减轻慢性阻塞性肺疾病患者运动期间的动态肺过度充气。
Am J Respir Crit Care Med. 1996 Mar;153(3):967-75. doi: 10.1164/ajrccm.153.3.8630581.
7
Bronchodilator response of advanced lung function parameters depending on COPD severity.根据慢性阻塞性肺疾病(COPD)严重程度,晚期肺功能参数的支气管扩张剂反应。
Int J Chron Obstruct Pulmon Dis. 2016 Nov 25;11:2939-2950. doi: 10.2147/COPD.S111573. eCollection 2016.
8
Inspiratory drive is related to dynamic pulmonary hyperinflation in COPD patients.吸气驱动与 COPD 患者的动态性肺过度充气有关。
Int J Chron Obstruct Pulmon Dis. 2013;8:169-73. doi: 10.2147/COPD.S38320. Epub 2013 Mar 28.
9
Response of lung volumes to inhaled salbutamol in a large population of patients with severe hyperinflation.大量严重肺过度充气患者吸入沙丁胺醇后肺容积的反应。
Chest. 2002 Apr;121(4):1042-50. doi: 10.1378/chest.121.4.1042.
10
A pilot comparison of helium dilution and plethysmographic lung volumes to assess the impact of a long-acting bronchodilator on lung hyperinflation in COPD.氦稀释法与体描法肺容积测定评估长效支气管扩张剂对 COPD 患者肺过度充气影响的初步比较。
Pulm Pharmacol Ther. 2009 Dec;22(6):522-5. doi: 10.1016/j.pupt.2009.05.005. Epub 2009 May 27.

引用本文的文献

1
Updated Perspectives on the Role of Biomechanics in COPD: Considerations for the Clinician.关于生物力学在 COPD 中的作用的最新观点:临床医生的考虑因素。
Int J Chron Obstruct Pulmon Dis. 2022 Oct 17;17:2653-2675. doi: 10.2147/COPD.S339195. eCollection 2022.
2
Optoelectronic Plethysmography has Improved our Knowledge of Respiratory Physiology and Pathophysiology.光电体积描记法增进了我们对呼吸生理学和病理生理学的认识。
Sensors (Basel). 2008 Dec 5;8(12):7951-7972. doi: 10.3390/s8127951.
3
Inhaled Beta Agonist Bronchodilator Does Not Affect Trans-diaphragmatic Pressure Gradient but Decreases Lower Esophageal Sphincter Retention Pressure in Patients with Chronic Obstructive Pulmonary Disease (COPD) and Gastroesophageal Reflux Disease (GERD).
吸入性β受体激动剂支气管扩张剂对慢性阻塞性肺疾病(COPD)合并胃食管反流病(GERD)患者的跨膈压梯度无影响,但会降低食管下括约肌的静息压力。
J Gastrointest Surg. 2016 Oct;20(10):1679-82. doi: 10.1007/s11605-016-3192-1. Epub 2016 Jun 27.
4
Longitudinal lung volume changes in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者的肺容积纵向变化。
Lung. 2013 Aug;191(4):405-12. doi: 10.1007/s00408-013-9478-0. Epub 2013 May 29.
5
Beyond lung function in COPD management: effectiveness of LABA/LAMA combination therapy on patient-centred outcomes.慢性阻塞性肺疾病管理中肺功能之外的因素:长效β2受体激动剂/长效毒蕈碱受体拮抗剂联合治疗对以患者为中心结局的有效性
Prim Care Respir J. 2012 Mar;21(1):101-8. doi: 10.4104/pcrj.2011.00102.
6
Update on the roles of distal airways in COPD.COPD 中远端气道作用的研究进展。
Eur Respir Rev. 2011 Mar;20(119):7-22. doi: 10.1183/09059180.10010610.
7
Abdominal muscle fatigue following exercise in chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者运动后腹肌疲劳。
Respir Res. 2010 Feb 4;11(1):15. doi: 10.1186/1465-9921-11-15.
8
A pilot study of inspiratory capacity and resting dyspnea correlations in exacerbations of COPD and asthma.慢性阻塞性肺疾病(COPD)和哮喘急性加重期吸气能力与静息性呼吸困难相关性的一项初步研究。
Int J Chron Obstruct Pulmon Dis. 2007;2(4):651-6.
9
Effect of salbutamol on lung function and chest wall volumes at rest and during exercise in COPD.沙丁胺醇对慢性阻塞性肺疾病(COPD)患者静息及运动时肺功能和胸壁容积的影响。
Thorax. 2005 Nov;60(11):916-24. doi: 10.1136/thx.2004.037937. Epub 2005 Jun 30.